<PAGE> 1
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
SCHEDULE 13D/A
Under the Securities Exchange Act of 1934
(Amendment No. 1 )*
Hypertension Diagnostics, Inc.
- --------------------------------------------------------------------------------
(Name of Issuer)
Common Stock, $.01 Par Value
- --------------------------------------------------------------------------------
(Title of Class of Securities)
44914V 10 4
- --------------------------------------------------------------------------------
(CUSIP Number)
Girard P. Miller
Lindquist & Vennum P.L.L.P.
4200 IDS Center
80 South Eighth Street
Minneapolis, Minnesota 55402
Telephone: (612) 371-2467
- --------------------------------------------------------------------------------
(Name, Address and Telephone Number of Person Authorized to
Receive Notices and Communications)
February 14, 2000
- --------------------------------------------------------------------------------
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to
report the acquisition which is the subject of this Schedule 13D, and is filing
this schedule because of ss. 240. 13d-1(e), 240. 13d-1(f) or 240. 13d-1(g),
check the following box / /.
Note: Schedules filed in paper format shall include a signed original
and five copies of the schedule, including all exhibits. See Rule
13d-7(b) for other parties to whom copies are to be sent.
*The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which
would alter disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be
deemed to be "filed" for the purpose of section 18 of the Securities Exchange
Act of 1934 ("Act") or otherwise subject to the liabilities of that section of
the Act but shall be subject to all other provisions of the Act (however, see
the Notes).
<PAGE> 2
CUSIP NO. 44914V 10 4 13D PAGE 2 OF 6 PAGES
--------------------- -- --
- --------------------------------------------------------------------------------
1 NAMES OF REPORTING PERSONS/I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS
(ENTITIES ONLY)
Jay N. Cohn, M.D.
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(See Instructions)
(a) [ ]
(b) [ ]
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 SOURCE OF FUNDS (See Instructions)
NA
- --------------------------------------------------------------------------------
5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT
TO ITEM 2(d) OR 2(e) [ ]
- --------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
United States
- --------------------------------------------------------------------------------
7 SOLE VOTING POWER
NUMBER OF
498,052
SHARES -----------------------------------------------------------------
8 SHARED VOTING POWER
BENEFICIALLY
-0-
OWNED BY EACH -----------------------------------------------------------------
9 SOLE DISPOSITIVE POWER
REPORTING
498,052
PERSON -----------------------------------------------------------------
10 SHARED DISPOSITIVE POWER
WITH:
-0-
- --------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
498,052
- --------------------------------------------------------------------------------
12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES (See Instructions) [ ]
- --------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
9.0%
- --------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON (See Instructions)
IN
- --------------------------------------------------------------------------------
<PAGE> 3
ITEM 1. Security and Issuer
This statement relates to shares of the common stock, par value $0.01
per share (the "Common Stock"), of Hypertension Diagnostics, Inc., a
Minnesota Corporation (the "Issuer"), whose principal executive
officers are located at 2915 Waters Road, Suite 108, Egan, MN
55121-1562.
ITEM 2. Identity and Background
(a) Name. This statement is being filed by Jay N. Cohn, M.D.
(b) The address of Dr. Cohn is 4848 Russell Avenue South,
Minneapolis, Minnesota 55410.
(c) Dr. Cohn is a Professor of Medicine at the University of
Minnesota Medical School.
(d) Criminal Proceedings. None.
(e) Litigation. None.
(f) Citizenship. Jay N. Cohn is a citizen of the United States.
ITEM 3. Source And Amount of Funds or Other Consideration
(Grant of Option)
ITEM 4. Purpose of Transaction
On August 31, 1998, Dr. Cohn was granted an option to purchase shares
of the Issuer in connection with his service as a director of the
Issuer. Pursuant to this option grant, Dr. Cohn became entitled to
purchase an additional 33,333 shares of the Issuer which vested during
calendar year 1999.
ITEM 5. Interest in Securities of the Issuer
(a) Dr. Cohn is the beneficial owner of 498,052 shares,
representing approximately 9.0% of the outstanding shares of
the Common Stock of the Issuer. The calculation of the
foregoing percentage is based on 5,109,235 shares of Common
Stock shown as being outstanding on the Form 10-QSB Quarterly
Report filed by the Issuer with the Securities and Exchange
Commission for the quarter ended September 30, 1999. Of the
498,052 shares, 423,878 are deemed owned due to currently
exercisable options.
Page 3 of 5 Pages
<PAGE> 4
(b) Dr. Cohn has sole power to vote or to direct the vote and the
sole power to dispose or to direct the disposition of the
shares.
(c) There have been no transactions by Dr. Cohn in the securities
of the Issuer during the past sixty days.
(d) Not applicable.
(e) Not applicable.
ITEM 6. Contracts, Arrangements, Understandings or Relationships with
Respect to Securities of Issuer
None.
ITEM 7. Materials to be filed as Exhibits
None.
Page 4 of 5 Pages
<PAGE> 5
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief,
I certify that the information set forth in this statement is true, complete and
correct.
February 12, 2000.
/s/Jay N. Cohn, M.D.
---------------------------
Jay N. Cohn, M.D.
Page 5 of 5 Pages
